Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Neurology
Disease Category: Autism

Trial Information

Seeking Participants with a Diagnosis of Autism Spectrum Disorder

Research at Beth Israel Deaconess Medical Center is investigating whether non-invasive repetitive transcranial magnetic stimulation can improve language skills in individuals with autism spectrum disorders.

• Transcranial magnetic stimulation (TMS) is an experimental way to transiently activate specific brain areas through the scalp that has been used for the past 20 years in neurology and psychiatry. Safety guidelines have been developed that will be closely followed. Past experience has documented efficacy of repetitive TMS in patients with language problems due to various diseases.
• Study involves up to 6 visits.
• Subjects will be asked to undergo a neurological exam, neuropsychological assessments, language assessment, MRI, and TMS.
• Study Eligibility: Subjects must be 18-65 years of age, diagnosed with autism spectrum disorders, have no history known genetic disorder (e.g., NF1, tuberous sclerosis), cerebral palsy, frank neurological damage, or significant dysmorphology.
• Subjects will be compensated $60 per visit for their participation.

If you are interested, or to learn more, please contact Shirley at 617-667-5229 or sfecteau@bidmc.harvard.edu

Shirley Fecteau
Beth Israel Deaconess Medical Center, Division of Endocrinology & Metabolism
Center for Noninvasive Brain Stimulation
330 Brookline Avenue, KS 452

Boston, MA 02215
Phone: 617-667-5229
EMail: sfecteau@bidmc.harvard.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.